insights_auto
Why is SCYX up 10.45%?
Dive Deeperchevron_right
SCYX:NASDAQ
SCYNEXIS Inc
$4.86
arrow_upward
+10.45%(+0.46) 1D
$5.12
arrow_upward
+5.35% (+0.26)bedtimeAfter hours
Closed: Sep 22, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCYX...
Open
$4.47
High
$4.94
Low
$4.36
Mkt. cap
48.36M
Avg. vol.
74.74K
Volume
0.00
52-wk high
$9.12
52-wk low
$3.53
EPS
-$2.16
Beta
1.11
Shares outstanding
9.95M
No. of employees
18
Open
$4.47
High
$4.94
Low
$4.36
Mkt. cap
48.36M
Avg. vol.
74.74K
Volume
0.00
52-wk high
$9.12
52-wk low
$3.53
EPS
-$2.16
Beta
1.11
Shares outstanding
9.95M
No. of employees
18
News stories
From web sources and news partners
TipRanks
·
20 hours ago
SCYNEXIS adds veteran biopharma leader to board
Investing.com
·
21 hours ago
Scynexis appoints Steven Burke to board of directors
Stock Titan
·
21 hours ago
Scynexis (NASDAQ: SCYX) adds kidney drug specialist to its board
Stock Titan
·
21 hours ago
SCYNEXIS Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of Directors
About SCYNEXIS Inc
CEO-
Employees18
FoundedJan 1, 1999
HeadquartersJersey City, New Jersey, United States
SectorPharmaceutical industry
Websitescynexis.com